A1 Refereed original research article in a scientific journal

Twenty-four-month α-galactosidase A replacement therapy in Fabry disease has only minimal effects on symptoms and cardiovascular parameters

Authors: Koskenvuo J., Hartiala J., Nuutila P., Kalliokoski R., Viikari J., Engblom E., Penttinen M., Knuuti J., Mononen I., Kantola I.

Publication year: 2008

Journal: Journal of Inherited Metabolic Disease

Journal name in source: Journal of Inherited Metabolic Disease

Volume: 31

Issue: 3

First page : 432

Last page: 441

Number of pages: 10

ISSN: 01418955 15732665

DOI: https://doi.org/10.1007/s10545-008-0848-3

Web address : https://api.elsevier.com/content/abstract/scopus_id/45849123200